Abstract
Nanna Finnerup graduated from the Medical School at Aarhus University, Denmark, in 1993, and after an internship worked at the Department of Neurology and Clinical Neurophysiology at the University of Copenhagen, Denmark. Since 1998 she has worked at the Danish Pain Research Center at Aarhus University. She obtained her degree of Doctor of Medical Sciences from Aarhus University in 2008, and is currently Associate Research Professor at the Danish Pain Research Center. Her main research interest is the pathophysiology and therapy of neuropathic pain, with particular focus on the mechanisms of central pain and pharmacological treatment of neuropathic pain. Dr Finnerup is a Management Committee Member of the Special Interest Group on Neuropathic Pain (NeuPSIG) of the International Association for the Study of Pain and a board member of the Scandinavian Association for the Study of Pain (SASP). She is a member of the Editorial Advisory Board of the Scandinavian Journal of Pain, the Encyclopedia of Pain and Pain Management.
Financial & competing interests disclosure
N Finnerup receives research funding from the Europain Investigational Medicines Initiative, which is a public–private partnership between the pharmaceutical industry and the EU. N Finnerup has also received research funding from Grünenthal and served as consultant for Grünenthal and Pfizer. N Finnerup has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.